Biosante Pharmaceuticals Aktie
62,00
EUR
+0,50
EUR
+0,81
%
67,57
USD
-0,37
USD
-0,54
%
Werbung
Biosante Pharmaceuticals Aktie Analyse
24.05.16 | Biosante Pharmaceuticals Hold | Standpoint Research | |
04.08.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
15.07.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
18.05.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
10.04.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC |
Werbung
Werbung